(Q33156913)

22 July 2017

Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation (English)

1 reference

22 July 2017

Helen J Lachmann

5

0 references

author name string

Ashutosh D Wechalekar

1

1 reference

22 July 2017

Mark Offer

2

1 reference

22 July 2017

Julian D Gillmore

3

1 reference

22 July 2017

Philip N Hawkins

4

1 reference

22 July 2017

language of work or name

1 reference

17 December 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

22 July 2017

1 reference

22 July 2017

6

1 reference

22 July 2017

2

1 reference

22 July 2017

128-133

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpcardio1423

22 July 2017

0 references

cites work

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPCARDIO1423

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

12 December 2020

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

1 reference

12 December 2020

Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.

1 reference

12 December 2020

Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin

1 reference

12 December 2020

The classification of amyloid deposits in clinicopathological practice

1 reference

12 December 2020

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans

1 reference

12 December 2020

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

1 reference

12 December 2020

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

1 reference

12 December 2020

Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis

1 reference

12 December 2020

Diagnosis and management of the cardiac amyloidoses

1 reference

12 December 2020

Perspectives in treatment of AL amyloidosis

1 reference

12 December 2020

99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy

1 reference

12 December 2020

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

1 reference

12 December 2020

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

1 reference

12 December 2020

The molecular biology and clinical features of amyloid neuropathy

1 reference

12 December 2020

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

12 December 2020

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPCARDIO1423

1 reference

Dimensions Publication ID

22 July 2017

0 references

1 reference